JSR Life Sciences, the life sciences-focused business unit of JSR Corporation, announced today that it has appointed Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International (MBLI) effective immediately. This leadership transition at MBLI comes on the heels of JSR’s recent acquisition of contract research organization, Crown Biosciences in which JSR sees great potential for synergy.  Whereas MBLI specializes in detecting and analyzing disease biomarkers and pathways, Crown’s expertise lies in supporting drug discovery, development and…